Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society.

Andropause Critical Pathways Estrogen Replacement Therapy Female Hormone Replacement Therapy Hot Flashes Humans Menopause Middle Aged
Breast cancer Cardiovascular disease Climacteric Hormone replacement therapy Hot flushes Menopause Night sweats Osteoporosis Women

Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 16 5 2022
medline: 10 8 2022
entrez: 15 5 2022
Statut: ppublish

Résumé

This care pathway from the European Menopause and Andropause Society (EMAS) provides an updated pathway for monitoring and guidance of women at midlife, focusing on those approaching the end of the reproductive life-cycle, going through the menopausal transition and beyond. The care pathway is written by professionals involved in women's health and provides a stepwise individualized approach, stratified according to needs, symptoms and reproductive stage. Furthermore, the pathway provides details on screening for chronic diseases related to menopause and ageing. Treatment options for climacteric symptoms range from menopausal hormone therapy to non-hormonal alternatives and lifestyle modifications. Therapy should be tailored to personal needs and wishes. The pathway aims to offer a holistic, balanced approach for monitoring middle-aged women, aiming to control health problems effectively and ensure healthy ageing.

Identifiants

DOI: 10.1016/j.maturitas.2022.04.008 PMID: 35569270
pubmed: 35569270
pii: S0378-5122(22)00090-1
doi: 10.1016/j.maturitas.2022.04.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-14

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

1. Irene Lambrinoudaki: None declared. 2.Eleni Armeni: None declared. 3. Dimitrios G. Goulis: None declared. 4. Silvia Bretz: None declared. 5. Iuliana Ceausu: None declared. 6. Fatih Durmusoglu: None declared. 7. Risto Erkkola: None declared. 8. Ivan Fistonic: has received consulting fees in the past 3 years from Fotona Inc. 9. Marco Gambacciani: has received speaker and consulting fees in the past 3 years from MSD, Theramex and Bayer. 10. Marije Geukes: None declared. 11. Haitham Hamoda: None declared. 12. Caiomhe Hartley: None declared. 13. Angelica Lindén Hirschberg in the past 3 years has received grant support from ITF Research Pharma for the “Blissafe” study.

Auteurs

Irene Lambrinoudaki (I)

Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece. Electronic address: ilambrinoudaki@med.uoa.gr.

Eleni Armeni (E)

Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece.

Dimitrios Goulis (D)

Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece.

Silvia Bretz (S)

Clinica Silvia Bretz, Rio de Janeiro, Brazil.

Iuliana Ceausu (I)

Department of Obstetrics and Gynecology I, "Carol Davila" University of Medicine and Pharmacy, "Dr. I. Cantacuzino" Clinical Hospital, Bucharest, Romania.

Fatih Durmusoglu (F)

Istanbul Medipol International School of Medicine, Istanbul, Turkey.

Risto Erkkola (R)

Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland.

Ivan Fistonic (I)

Institute for Women's Health, Zagreb, Croatia.

Marco Gambacciani (M)

Menopause and Osteoporosis Unit, San Rossore Clinical Center, Pisa, Italy.

Marije Geukes (M)

Department of Obstetrics and Gynecology, Ziekenhuisgroep Twente (Hospital Group Twente), Post Box 7600, 7600 SZ Almelo, the Netherlands.

Haitham Hamoda (H)

Department Gynaecology, King's College Hospital, Denmark Hill, London SE5 9RS, UK.

Caiomhe Hartley (C)

Menopause Health Clinic, Dublin, Ireland.

Angelica Lindén Hirschberg (AL)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.

Blazej Meczekalski (B)

Department of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland.

Nicolas Mendoza (N)

Department of Obstetrics and Gynecology, University of Granada, Spain.

Alfred Mueck (A)

Department of Women's Health, University Hospital Tuebingen, Germany; Beijing OB/GYN Hospital, Capital Medical University, China.

Antonina Smetnik (A)

Department of Gynecological Endocrinology, National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Healthcare of the Russian Federation, Moscow, Russia.

Petra Stute (P)

Department of Obstetrics and Gynecology, University Clinic Inselspital, Bern, Switzerland.

Mick van Trotsenburg (M)

Department of Obstetrics and Gynecology, University Hospital St. Poelten-Lilienfeld, Austria.

Margaret Rees (M)

Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Développement sexuel › Climatère › Andropause › Menopause, wellbeing and health: A care...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Services de santé polyvalents › Planification des soins du patient › Programme clinique › Menopause, wellbeing and health: A care...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Hormonothérapie substitutive › Oestrogénothérapie substitutive › Menopause, wellbeing and health: A care...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Hormonothérapie substitutive › Menopause, wellbeing and health: A care...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Bouffées de chaleur › Menopause, wellbeing and health: A care...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Menopause, wellbeing and health: A care...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Développement sexuel › Climatère › Ménopause › Menopause, wellbeing and health: A care...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Menopause, wellbeing and health: A care...